Burnham Institute, JHU Using Invitrogen miRNA Platform for Stem Cell Research | GenomeWeb
BOSTON (GenomeWeb News) — Embryonic stem-cell researchers at the Burnham Institute and Johns Hopkins University are using Invitrogen's NCode miRNA array platform in their research, according to a company official.
The collaborations add embryonic stem-cell research to the list of potential areas that the nascent technology could target — an arena Invitrogen believes could become a boon to its miRNA business. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.